Period:
Draw Mode:
| Volume | 413,688 |
|
|||||
| News | - | ||||||
| Day High | 39.26 | Low High |
|||||
| Day Low | 38.23 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Halozyme Therapeutics Incorporated | HALO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.06 | -0.16% | 38.41 | 14:21:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 38.51 | 38.23 | 39.26 | 38.47 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,099 | 413,688 | $ 38.61 | $ 15,972,415 | - | 29.85 - 59.46 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:21:49 | 2 | $ 38.415 | USD |
Halozyme Therapeutics (HALO) Options Flow Summary
Halozyme Therapeutics Incorporated Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.07B | 131.92M | - | 660.12M | 202.13M | 1.53 | 25.06 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Halozyme Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HALO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 39.77 | 40.54 | 38.14 | 39.27 | 696,534 | -1.36 | -3.42% |
| 1 Month | 43.07 | 43.33 | 37.43 | 39.84 | 930,159 | -4.66 | -10.82% |
| 3 Months | 36.85 | 45.00 | 35.71 | 41.09 | 989,646 | 1.56 | 4.23% |
| 6 Months | 34.79 | 45.00 | 29.85 | 37.22 | 1,137,830 | 3.62 | 10.41% |
| 1 Year | 39.07 | 59.46 | 29.85 | 43.04 | 1,240,446 | -0.66 | -1.69% |
| 3 Years | 26.12 | 59.46 | 25.69 | 41.68 | 1,188,900 | 12.29 | 47.05% |
| 5 Years | 17.92 | 59.46 | 12.71 | 33.09 | 1,157,035 | 20.49 | 114.34% |
Halozyme Therapeutics Description
| Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. |